SCHEMBL463305

SCHEMBL463305

CCC(C(=O)O)c1c(C)nc2c(C)c(-c3cccc(Cl)c3)nn2c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
PSIP1 O75475 1/20 0.38
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
PTGFR P43088 3/20 0.36
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
TP53 P04637 1/20 0.35
THRB P10828 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
MDM2 Q00987 1/20 0.35
GRM5 P41594 1/20 0.35
PIN1 Q13526 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL463413 0.91 KDM4E (0.39) KDM4EPSIP1KMT2AALDH1A1MEN1
SCHEMBL461591 0.80 GRM5 (0.37) KMT2APDE4APDE4CPDE4DTP53
SCHEMBL461161 0.77 PDE4A (0.41) KDM4EKMT2AALDH1A1MEN1PDE4A
SCHEMBL463049 0.77 KDM4E (0.50) KDM4EKMT2AALDH1A1MEN1TP53
SCHEMBL10175062 0.77 PDE4A (0.41) KDM4EKMT2AALDH1A1MEN1PDE4A
SCHEMBL461920 0.75 CYP3A4 (0.44) PSIP1TP53THRBPIN1CYP3A4
SCHEMBL470322 0.73 PDE4A (0.39) KDM4EKMT2AALDH1A1MEN1PDE4A
SCHEMBL460739 0.71 KDM4E (0.51) KDM4EKMT2AALDH1A1MEN1TP53
SCHEMBL461469 0.71 XPO1 (0.46) KDM4EKMT2AALDH1A1MEN1PDE4A
SCHEMBL5095459 0.69 KDM4E (0.47) KDM4EPTGFRTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2614064-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Bristol-Myers Squibb Company (US) 2013-07-17 EP disclosed
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed